Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Characterization of a cancer cachectic factor

P Todorov1, P Cariuk, T McDevitt

  • 1CRC Nutritional Biochemistry Research Group, Pharmaceutical Sciences Institute, Aston University, Birmingham UK.

Nature
|February 22, 1996
PubMed
Summary

Researchers identified a novel 24K proteoglycan responsible for cancer cachexia in mice and humans. This discovery offers a potential target for understanding and treating cancer-related weight loss.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Imaging methods in polymyalgia rheumatica: a systematic review.

Rheumatology international·2023
Same author

The impact of endoscopic ultrasound on the management and outcome of patients with oesophageal cancer: an update of a systematic review.

Clinical radiology·2022
Same author

Correction to: Waterbirth: a national retrospective cohort study of factors associated with its use among women in England.

BMC pregnancy and childbirth·2021
Same author

Waterbirth: a national retrospective cohort study of factors associated with its use among women in England.

BMC pregnancy and childbirth·2021
Same author

Adipogenic potential of stem cells derived from rabbit subcutaneous and visceral adipose tissue in vitro.

In vitro cellular & developmental biology. Animal·2016
Same author

Injectable hydrogel promotes early survival of induced pluripotent stem cell-derived oligodendrocytes and attenuates longterm teratoma formation in a spinal cord injury model.

Biomaterials·2016

Area of Science:

  • Biochemistry
  • Oncology
  • Immunology

Background:

  • Cancer cachexia is a complex wasting syndrome linked to pro-inflammatory cytokines like tumor necrosis factor-alpha and interleukins.
  • Previous attempts to correlate cytokine levels with cachexia severity have been challenging, and some factors may induce weight loss through toxicity.

Purpose of the Study:

  • To identify the specific catabolic factors mediating cachexia in the murine adenocarcinoma MAC16 model.
  • To investigate the potential role of these factors in human cancer cachexia.

Main Methods:

  • Isolation of cachexia-mediating factors from MAC16 tumor-bearing mice using a specific antibody.
  • Characterization of the isolated factor's molecular mass and biological activity in vivo.
  • Detection of the factor in urine samples from cancer patients and control groups.

Related Experiment Videos

Main Results:

  • A 24K proteoglycan was isolated and found to induce skeletal muscle catabolism, leading to cachexia in vivo.
  • This 24K material was detected in the urine of cachectic cancer patients.
  • The 24K material was absent in normal individuals, trauma patients, and cancer patients without significant weight loss.

Conclusions:

  • Circulating catabolic factors, specifically a 24K proteoglycan, are responsible for cancer cachexia in the MAC16 mouse model.
  • The presence of this 24K material in human cachectic cancer patients suggests a conserved mechanism for cancer cachexia in mice and humans.